10.12.26 -- Smarter Decisions Across The Clinical Development Lifecycle

Learn how biospecimens, clinical data, cohort identification, and specialized laboratory services come together to support complex translational and biomarker research initiatives.

Gain insight into a more intuitive IRB submission experience that can help reduce friction, improve transparency, and support today’s virtual research workflows.

Where better medicines begin. Early phase decisions are mission critical to the long-term success of your promising innovations. See how a multi-disciplinary early phase approach can bolster your clinical evidence.

Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.

Global clinical trials need central laboratory networks able to scale across countries while keeping biomarker and biospecimen data consistent from one study site to the next.

Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.

Move drug development into the modern era with a CRO that offers assay development and validation, bioanalytical testing, sample prep, and more.